Ascentage Pharma Group Stock Performance

AAPG Stock   23.82  0.62  2.67%   
The firm shows a Beta (market volatility) of 0.3, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Ascentage Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ascentage Pharma is expected to be smaller as well. At this point, Ascentage Pharma has a negative expected return of -0.45%. Please make sure to confirm Ascentage Pharma's value at risk, rate of daily change, and the relationship between the total risk alpha and kurtosis , to decide if Ascentage Pharma performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Ascentage Pharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Actual Historical Performance (%)

One Day Return
2.67
Five Day Return
(2.26)
Year To Date Return
(9.67)
Ten Year Return
37.05
All Time Return
37.05
1
Ascentage Pharma Group International Shares Gap Up Still a Buy
12/18/2025
2
Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday
12/23/2025
3
Ascentage Pharma Sets Out Board Line-Up and Key Committee Roles - TipRanks
12/30/2025
4
Ascentage Pharma sets out board line-up and key committee roles - MSN
01/08/2026
5
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference - Chartmill
01/14/2026
6
Ascentage Pharma Group International Shares Gap Up Time to Buy
02/05/2026
7
A medida que la atencin mundial regresa a Venezuela, AAPG ofrece informacin objetiva sobre geociencias y dilogo tcnico
02/11/2026
8
Brokerages Set Ascentage Pharma Group International Unsponsored ADR Price Target at 48.40
02/13/2026
Begin Period Cash FlowB
Total Cashflows From Investing Activities-362 M

Ascentage Pharma Relative Risk vs. Return Landscape

If you would invest  3,271  in Ascentage Pharma Group on November 17, 2025 and sell it today you would lose (889.00) from holding Ascentage Pharma Group or give up 27.18% of portfolio value over 90 days. Ascentage Pharma Group is currently does not generate positive expected returns and assumes 3.4748% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Ascentage, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Ascentage Pharma is expected to under-perform the market. In addition to that, the company is 4.55 times more volatile than its market benchmark. It trades about -0.13 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of volatility.

Ascentage Pharma Target Price Odds to finish over Current Price

The tendency of Ascentage Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 23.82 90 days 23.82 
about 92.4
Based on a normal probability distribution, the odds of Ascentage Pharma to move above the current price in 90 days from now is about 92.4 (This Ascentage Pharma Group probability density function shows the probability of Ascentage Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Ascentage Pharma has a beta of 0.3. This suggests as returns on the market go up, Ascentage Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ascentage Pharma Group will be expected to be much smaller as well. Additionally Ascentage Pharma Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Ascentage Pharma Price Density   
       Price  

Predictive Modules for Ascentage Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascentage Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
20.1723.6427.11
Details
Intrinsic
Valuation
LowRealHigh
21.4428.7732.24
Details
2 Analysts
Consensus
LowTargetHigh
41.6045.7150.74
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.63-0.35-0.1
Details

Ascentage Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ascentage Pharma is not an exception. The market had few large corrections towards the Ascentage Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ascentage Pharma Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ascentage Pharma within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.43
β
Beta against Dow Jones0.30
σ
Overall volatility
3.12
Ir
Information ratio -0.14

Ascentage Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascentage Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascentage Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ascentage Pharma generated a negative expected return over the last 90 days
Ascentage Pharma has high historical volatility and very poor performance
Ascentage Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 980.65 M. Net Loss for the year was (395.25 M) with profit before overhead, payroll, taxes, and interest of 354.93 M.
Ascentage Pharma generates negative cash flow from operations
Ascentage Pharma has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Brokerages Set Ascentage Pharma Group International Unsponsored ADR Price Target at 48.40

Ascentage Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ascentage Stock often depends not only on the future outlook of the current and potential Ascentage Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascentage Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding302.1 M
Cash And Short Term Investments1.2 B

Ascentage Pharma Fundamentals Growth

Ascentage Stock prices reflect investors' perceptions of the future prospects and financial health of Ascentage Pharma, and Ascentage Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ascentage Stock performance.

About Ascentage Pharma Performance

By analyzing Ascentage Pharma's fundamental ratios, stakeholders can gain valuable insights into Ascentage Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ascentage Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ascentage Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 95.21  90.45 
Return On Tangible Assets(0.14)(0.15)
Return On Capital Employed(0.29)(0.31)
Return On Assets(0.14)(0.15)
Return On Equity(1.76)(1.85)

Things to note about Ascentage Pharma performance evaluation

Checking the ongoing alerts about Ascentage Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ascentage Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ascentage Pharma generated a negative expected return over the last 90 days
Ascentage Pharma has high historical volatility and very poor performance
Ascentage Pharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 980.65 M. Net Loss for the year was (395.25 M) with profit before overhead, payroll, taxes, and interest of 354.93 M.
Ascentage Pharma generates negative cash flow from operations
Ascentage Pharma has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Brokerages Set Ascentage Pharma Group International Unsponsored ADR Price Target at 48.40
Evaluating Ascentage Pharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ascentage Pharma's stock performance include:
  • Analyzing Ascentage Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ascentage Pharma's stock is overvalued or undervalued compared to its peers.
  • Examining Ascentage Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Ascentage Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ascentage Pharma's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Ascentage Pharma's stock. These opinions can provide insight into Ascentage Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ascentage Pharma's stock performance is not an exact science, and many factors can impact Ascentage Pharma's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Ascentage Stock analysis

When running Ascentage Pharma's price analysis, check to measure Ascentage Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascentage Pharma is operating at the current time. Most of Ascentage Pharma's value examination focuses on studying past and present price action to predict the probability of Ascentage Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascentage Pharma's price. Additionally, you may evaluate how the addition of Ascentage Pharma to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world